Sepracor-Looks very promising Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Sepracor-Looks very promising

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: j_fir2 who wrote (2241)	4/6/1999 5:49:00 PM
From: Biomaven	of 10280

Well my fantasy SEPR drug is desmethyl sibutramine, not "Super Prozac." Remember that Meridia was originally developed as an anti-depressant. I have to believe that a safe and effective antidepressant that "incidentally" also causes weight loss might cause as much stir as Viagra. On the other hand, if SEPR is ever going to get a patent challenge this might be it. Not because the patent is weak (being both a metabolite and a chiral switch it's actually strong), but because Knoll will have nothing to lose by a challenge. Knoll is also going to be a tad "upset" at having their 5 year patent extension sidestepped, and by a better drug. Just as the pharmas routinely challenge new generics, so I suspect might Knoll with Meridia II. Peter

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next